Limited-time offer
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
Dublin-domiciled Horizon Pharma has tabled a hostile bid — valued at $3bn (€2.74bn) — for US-based speciality pharmaceutical company Depomed.
Wed, 08 Jul, 2015
News
Thursday, March 26, 2026 - 11:00 PM
Friday, March 27, 2026 - 7:00 AM
Friday, March 27, 2026 - 6:00 AM